Ryan Rountree
Inventor
Stats
- 0 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 9 US Applications Filed
- 28 Total Citation Count
- Jul 13, 2022 Most Recent Filing
- Oct 16, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| BAVARIAN NORDIC A/S | 1
1 2 | 2013
2014 2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| San Francisco, CA, US | Oct 10, 24 - Oct 10, 24 |
| San Jose, CA, US | Oct 08, 15 - Jul 08, 21 |
| San Mateo, CA, US | Aug 02, 18 - Sep 12, 23 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07D: | HETEROCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0336,595 | 2024 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY | 0 |
| 11753652 | 2023 | Cassette encoding a FPV/brachyury fusion protein | 0 |
| 11654189 | 2023 | Compositions and methods for enhancing the stability of transgenes in poxviruses | 0 |
| 2021/0338,788 | 2021 | Compositions and Methods for Enhancing the Stability of Transgenes in Poxviruses | 0 |
| 2021/0205,429 | 2021 | Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.